Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

U.S. administers 296.4 million doses of COVID-19 vaccines - CDC

Published 06/01/2021, 04:59 PM
Updated 06/01/2021, 05:01 PM
© Reuters. FILE PHOTO: A woman receives a COVID-19 vaccine at a clinic in Philadelphia, Pennsylvania, U.S., May 18, 2021. REUTERS/Hannah Beier/File Photo

(Reuters) - The United States has administered 296,404,240 doses of COVID-19 vaccines in the country as of Tuesday morning and distributed 366,317,045 doses, the U.S. Centers for Disease Control and Prevention said on Tuesday.

Those figures are up from the 294,928,850 vaccine doses the CDC said had gone into arms by May 30 out of 366,316,945 doses delivered.

The agency said 168,489,729 people had received at least one dose while 135,867,425 people are fully vaccinated as of Tuesday.

The CDC tally includes two-dose vaccines from Moderna (NASDAQ:MRNA) and Pfizer/BioNTech, as well as Johnson & Johnson (NYSE:JNJ)'s one-shot vaccine as of 6:00 a.m. ET on Tuesday.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.